|

Glucagon-like peptide-1 receptor agonists (GLP 1 RA) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: GLP-1 receptor agonists

Top Sponsors

  • University of Pennsylvania1

Indications

  • Renal Insufficiency, Chronic1
  • Diabetic Nephropathies1
  • Diabetes1
  • Kidney Diseases1
  • Diabetes Mellitus, Type 21

Philadelphia, Pennsylvania1 trial

Transformative Research in Diabetic Nephropathy 2.0

Penn Presbyterian Medical Center

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.